Pharmaceutical Market Europe
@PMLiVEcom
Followers
16K
Following
358
Media
634
Statuses
21K
News & analysis of healthcare, pharma and biotech. Magazines, directories, profiles, jobs & awards.
Surrey, UK
Joined June 2009
NICE recommends ALK’s immunotherapy to target underlying cause of hay fever
pmlive.com
An estimated 26,800 people in England with moderate-to-severe cases could benefit from Itulazax
0
0
0
Roche’s Itovebi granted EC approval to treat advanced breast cancer patients
pmlive.com
Hormone receptor-positive breast cancer accounts for around 70% of all breast cancer cases
0
0
0
AstraZeneca unveils plans to boost US footprint with $50bn investment
pmlive.com
The funds will go towards establishing a multi-billion dollar drug substance facility in Virginia
0
0
0
Why fresh patient voices are critical to improve clinical trials outcomes
pmlive.com
Discover why diverse patient voices, especially first-time participants, are key to improving clinical trials. Boost recruitment, retention, and patient-centric research.
0
0
0
Eli Lilly/Almirall’s Ebglyss shows promise in atopic dermatitis patients with darker skin tones
pmlive.com
The inflammatory skin condition occurs in approximately 7.3% of adults in the US
0
0
0
Biogen to boost US manufacturing footprint with $2bn North Carolina investment
pmlive.com
The commitment is aimed at advancing the company's late-stage clinical pipeline
0
0
0
Sanofi to expand respiratory vaccines pipeline with $1.6bn Vicebio acquisition
pmlive.com
The deal includes an early-stage combination vaccine candidate for RSV and hMPV
0
0
0
In the latest issue of PME, Karen Harris explores how current market challenges are redefining the biotech landscape. Check out her article below: #Biotech #DrugFunding #Pharma #Health #PME.
pmlive.com
Short-term uncertainty is slowing investment activity, but the long-term outlook remains strong
0
0
0
Shared Care, Digital Tools, and AI: What Do Nurses Really Think?
pmlive.com
Shared care models, supported by effective communication and digital tools, are helping community nurses like Ashleigh Tropp empower patients and improve outcomes, especially in managing long-term...
0
0
0
US Payer Panel Insights Survey: Evolving Evidence Landscape and Priorities
pmlive.com
Download the first edition of the Petauri ‘US Payer Panel Insights Survey: Evolving Evidence Landscape and Priorities’ report
0
0
0
Genetic Digital Shortlisted for PM Society Digital Award for Epilepsy Meds App
pmlive.com
Genetic Digital has been shortlisted for a PM Society Digital Award for Epilepsy Meds, a mobile-first app that helps healthcare professionals make safer, patient-specific prescribing decisions in...
0
0
0
How brands can talk about sexual health on social media
pmlive.com
Find top tips on how to navigate censorship when posting information on intimate or sexual health on social media platforms.
0
0
0
EC approves SpringWorks Therapeutics’ Ezmekly to treat rare genetic disorder NF1
pmlive.com
Neurofibromatosis type 1 affects an estimated 135,000 people in the EU
0
1
0
AstraZeneca shares late-stage results for Tagrisso combination in lung cancer
pmlive.com
An estimated 2.4 million people globally are diagnosed with lung cancer each year
0
0
0
In Uptake's latest column, Jo Lopez explores how integrating AI across the commercialisation process can drive better outcomes: #HealthcareComms #HealthcareMarketing #AIinPharma #DrugLaunch #Pharma #Health #PME.
pmlive.com
How integrating AI across the commercialisation process can drive better outcomes
0
0
0
LEO Pharma gains access to Boehringer’s skin disease drug for €90m upfront
pmlive.com
Spevigo is already approved in over 40 countries to treat generalised pustular psoriasis
0
1
0
Alnylam’s Amvuttra approved by MHRA to treat rare heart disease ATTR-CM
pmlive.com
The drug has been authorised to treat both wild-type and hereditary forms of the disease
0
1
0
NICE recommends BeOne’s Brukinsa to treat mantle cell lymphoma on NHS
pmlive.com
Approximately 600 people are affected by the form of non-Hodgkin lymphoma every year in the UK
0
0
0
Johnson & Johnson’s TAR-200 granted FDA priority review to treat bladder cancer
pmlive.com
An estimated 84,870 people will be diagnosed with bladder cancer in the US this year
0
0
0
Check out Lindy Crimmins' article in the latest issue of PME on the substantial burden of sepsis and the impact of antibiotic resistance: #AntibioticResistance #AMR #Sepsis #Pharma #Health #PME.
pmlive.com
A WHO report emphasises the serious global impact of antimicrobial resistance, which exacerbates the substantial burden of sepsis on patients, HCPs and health systems
0
0
0